Immunologic studies of human breast cancer. I. Serum reactivity against a lymphoid cell line (Belev) derived from a breast cancer patient as detected by complement-fixation test.

Journal of the National Cancer Institute ·Vol. 47 ·No. 3 ·1971-09-00 ·Pages 511-7

Chan SP, Maca RD, Levine PH, Ting RC

Abstract

暂无摘要

MeSH Terms

Antigens, Neoplasm Breast Diseases/immunology Breast Neoplasms/immunology Cell Line Complement Fixation Tests Female Humans Lectins Lymphocytes/immunology Lymphoid Tissue/immunology

Chemicals

Antigens, Neoplasm Lectins

Authors & Affiliations

4 authors, click to expand affiliations / ORCID

Chan S P

Maca R D

Levine P H

Ting R C

Article Info

Journal

Journal of the National Cancer Institute

Abbr.

J Natl Cancer Inst

ISSN

0027-8874

Published

1971-09-00

Pages

511-7

Language

English

Region

United States

NLM ID

7503089

Subset

External Links

PubMed source View journal details

Analysis Services

Immunologic studies of human breast cancer. I. Serum reactivity against a lymphoid cell line (Belev) derived from a breast cancer patient as detected by complement-fixation test.

Contact

WeChat Official Account